Federal award (PURCHASE ORDER, fiscal year 2022)
Recipient: CAMBREX HIGH POINT, INC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2023-07-19 to 2024-07-18
Current total value of award: $10465
Description: PHARMACORE INC:1157345 [23-004791] RETESTING OF GLWL-01 REFERENCE STANDARD AND PROJECT SPECIFIC FUNDIN